
Doug Drysdale
@insidepharma
CEO @CybinInc (NYSE:CYBN) | Changing Minds | E&Y Entrepreneur of the Year | Inc. 5000 | Healthcare Investor & Advisor
ID: 298850585
https://cybin.com 15-05-2011 02:05:15
2,2K Tweet
2,2K Followers
510 Following



“It is gratifying that the U.S. FDA Commissioner Dr. Martin Makary shares our belief in the potential therapeutic value of these innovative treatments – a long-held belief that stands at the core of Cybin’s mission,” said Doug Drysdale, Chief Executive Officer of Cybin. Watch Dr.





#Cybin CEO Doug Drysdale will discuss partnerships, progress on #CYB003, upcoming milestones, and the #FDA and #psychedelics in a Water Tower Research LLC Fireside Chat next week, Thursday, May 29, 2025. Click here to register for the webcast: loom.ly/ORTJqz4

I recently met with mental health advocates and insurers during Mental Health Awareness Month. We’re spending billions on treatments—but too often, we don’t know if they’re working. That’s unacceptable. We’re building an outcomes-based system that delivers real results for





#AlphaNooner Live TOMORROW! at 12PM ET with Doug Drysdale Doug Drysdale CEO of CybinInc and Mackenzie Peterson Mackenzie P talking $CYBN #Psychedelics #MentalHealth #Wellness #Therapeutics



#ICYMI: Last week, Cybin CEO Doug Drysdale was featured in a fireside chat hosted by Jim Molloy at Alliance Global Partners (A.G.P.)'s Virtual Healthcare Showcase. Tune in to the replay to learn more about Cybin's progress with its lead clinical-stage programs CYB003 and CYB004,



Today on Tomi Lahren is Fearless: - Power of Psychedelics - Ketamine Benefits - Cybin CEO Doug Drysdale Joins - Big Pharma Breakthrough? - Symptom vs Cause? - Tricking Mental Illness x.com/i/broadcasts/1…


Future of Mental Health: Can Psychedelics Fix What Antidepressants Can’t? Tomi Lahren m.youtube.com/watch?v=Bo6892…